SARS-CoV-2 Omicron variants emerged in 2022 with >30 novel mutations in the spike alone. While most studies focus on receptor binding domain changes, mutations in the C-terminus of S1 (CTS1), adjacent ...

A research team led by distinguished professor Giuseppe Pezzotti at the Biomedical Engineering Center, Kansai Medical University (Japan), has demonstrated that differences in the molecular structures ...

Antibodies are an important defense against SARS-CoV-2, but the virus continues to evolve ways to evade them. Now, researchers have mapped how antibodies target a key region of the virus's spike ...

The Global Virus Network (GVN), representing eminent human and animal virologists from more than 90 Centers of Excellence and Affiliates in over 40 countries dedicated to advancing research, ...

A newly identified Covid-19 subvariant, BA.3.2, informally dubbed the "Cicada" variant, is drawing global attention after being detected in the United States and other regions. Emerging from the ...

Two of the seven defining mutations in the Delta variant spike protein arose through C→G transversions, a mutation type that is normally very rare in SARS-CoV-2 evolution. Nearly one-third of the ...

TAMPA, FL, USA (April 3, 2026) – The Global Virus Network (GVN), representing eminent human and animal virologists from more than 90 Centers of Excellence and Affiliates in over 40 countries dedicated ...

Human neural stem cells that help form the brain and spinal cord are highly susceptible to SARS-CoV-2, including omicron ...

Who bears responsibility for the COVID-19 pandemic? While a detailed forensic accounting will ultimately reveal the contribution of people and institutions to the current crisis, we must take care not ...

The Centers for Disease Control and Prevention has flagged a SARS-CoV-2 subvariant called BA.3.2 after identifying it in U.S. clinical samples and wastewater, adding to a growing international count ...

BA.3.2 spread internationally after first being identified in South Africa in November 2024, with detections rising from September 2025 and reports from at least 23 countries by 11 February 2026. U.S.